Conjecture: Structured Products

clock

In the latest Conjecture debate, our panellists from Barclays Wealth, Investec Structured Products and Morgan Stanley discussed UK Equity Income.

Click here to listen to the debate on demand Click here to become a member of Conjecture Figures from industry sources indicate that the number of IFAs using structured products within their client portfolios has been rising rapidly, both of packaged products and bespoke investments. This conjecture focuses on the practicalities around using structured investments and deposits in a client portfolio, pricing environments, different types of investments and how structured products fare when markets react wildly as they did in early August. The Structured Products panel includes:...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

While thematic funds offer diversification and a specialist knowledge base, investors must also consider the sensitivity to real bond yields inherent in these funds.

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
Deal volumes fell last year as rising interest rates brought the end of cheap money

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Ali H. Munawar, CEO of Pledge Therapeutics

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot